{"id":"https://openalex.org/W1965604161","doi":"https://doi.org/10.1182/blood-2012-06-438101","title":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance","display_name":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance","alternate_titles":[],"publication_year":2012,"publication_date":"2012-12-12","ids":{"openalex":"https://openalex.org/W1965604161","doi":"https://doi.org/10.1182/blood-2012-06-438101","mag":"1965604161","pmid":"https://pubmed.ncbi.nlm.nih.gov/23233657"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2012-06-438101","doi":"https://doi.org/10.1182/blood-2012-06-438101","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2012-06-438101","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1965604161"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://repub.eur.nl/pub/69768","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080712446","display_name":"Annemiek Broyl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Annemiek Broyl","raw_affiliation_strings":["Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006394021","display_name":"Rowan Kuiper","orcid":"https://orcid.org/0000-0002-3703-1762","observed_orcids":["https://orcid.org/0000-0002-3703-1762"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rowan Kuiper","raw_affiliation_strings":["Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089637265","display_name":"Mark van Duin","orcid":"https://orcid.org/0000-0002-6648-8171","observed_orcids":["https://orcid.org/0000-0002-6648-8171"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mark van Duin","raw_affiliation_strings":["Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Erasmus MC, Rotterdam, The Netherlands;","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012101669","display_name":"Bronno van der Holt","orcid":"https://orcid.org/0000-0001-6414-2671","observed_orcids":["https://orcid.org/0000-0001-6414-2671"]},"institutions":[{"id":"https://openalex.org/I4210145518","display_name":"Hovon","ror":"https://ror.org/056kpdx27","country_code":"NL","type":"other","lineage":["https://openalex.org/I4210145518"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Bronno van der Holt","raw_affiliation_strings":["HOVON Data Center Erasmus MC\u2013Daniel den Hoed, Rotterdam, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HOVON Data Center Erasmus MC\u2013Daniel den Hoed, Rotterdam, The Netherlands;","institution_ids":["https://openalex.org/I4210145518","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062591567","display_name":"Laila el Jarari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145518","display_name":"Hovon","ror":"https://ror.org/056kpdx27","country_code":"NL","type":"other","lineage":["https://openalex.org/I4210145518"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Laila el Jarari","raw_affiliation_strings":["HOVON Data Center Erasmus MC\u2013Daniel den Hoed, Rotterdam, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HOVON Data Center Erasmus MC\u2013Daniel den Hoed, Rotterdam, The Netherlands;","institution_ids":["https://openalex.org/I4210145518","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064702344","display_name":"Uta Bertsch","orcid":"https://orcid.org/0000-0001-5584-3951","observed_orcids":["https://orcid.org/0000-0001-5584-3951"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uta Bertsch","raw_affiliation_strings":["Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;","institution_ids":["https://openalex.org/I2802164966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083385949","display_name":"Sonja Zweegman","orcid":"https://orcid.org/0000-0002-5011-1820","observed_orcids":["https://orcid.org/0000-0002-5011-1820"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sonja Zweegman","raw_affiliation_strings":["Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands; and","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109348129","display_name":"Arjan Buijs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arjan Buijs","raw_affiliation_strings":["Departments of Medical Genetics and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medical Genetics and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007067641","display_name":"Dirk Hose","orcid":"https://orcid.org/0000-0003-0806-5223","observed_orcids":["https://orcid.org/0000-0003-0806-5223"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dirk Hose","raw_affiliation_strings":["Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;","institution_ids":["https://openalex.org/I2802164966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110098171","display_name":"Henk M. Lokhorst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Henk M. Lokhorst","raw_affiliation_strings":["Hematology, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055916434","display_name":"Hartmut Goldschmidt","orcid":"https://orcid.org/0000-0003-0961-0035","observed_orcids":["https://orcid.org/0000-0003-0961-0035"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hartmut Goldschmidt","raw_affiliation_strings":["Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany;","institution_ids":["https://openalex.org/I2802164966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002972322","display_name":"Pieter Sonneveld","orcid":"https://orcid.org/0000-0002-0808-2237","observed_orcids":["https://orcid.org/0000-0002-0808-2237"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pieter Sonneveld","raw_affiliation_strings":["Hematology, Erasmus MC, Rotterdam, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Erasmus MC, Rotterdam, Netherlands,","institution_ids":["https://openalex.org/I2801952686"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":9.6162,"has_fulltext":false,"cited_by_count":143,"citation_normalized_percentile":{"value":0.98507236,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"121","issue":"4","first_page":"624","last_page":"627"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.9599999785423279},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9359999895095825},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9480000138282776},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.8420000076293945},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2778540781","wikidata":"https://www.wikidata.org/wiki/Q21112029","display_name":"Cereblon","level":5,"score":0.9524511694908142},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.9405532479286194},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8146985173225403},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7691283226013184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.752264142036438},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6511317491531372},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5977186560630798},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5928021669387817},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.5476384162902832},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5006356239318848},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10720539093017578},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08563649654388428},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.0},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010447","descriptor_name":"Peptide Hydrolases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048868","descriptor_name":"Adaptor Proteins, Signal Transducing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060046","descriptor_name":"Maintenance Chemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":9,"locations":[{"id":"doi:10.1182/blood-2012-06-438101","doi":"https://doi.org/10.1182/blood-2012-06-438101","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2012-06-438101","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:23233657","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23233657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/5473279a-18ed-47bd-a4d9-5dead9c9d910","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/5473279a-18ed-47bd-a4d9-5dead9c9d910","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Broyl, A, Kuiper, R, van Duin, M, van der Holt, B, el Jarari, L, Bertsch, U, Zweegman, S, Buijs, A, Hose, D, Lokhorst, H M, Goldschmidt, H & Sonneveld, P 2013, 'High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance', Blood, vol. 121, no. 4, pp. 624-627. https://doi.org/10.1182/blood-2012-06-438101","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b004673c-42e3-4a4e-9767-44f0e03fbc6b","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/b004673c-42e3-4a4e-9767-44f0e03fbc6b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Broyl, A, Kuiper, R, van Duin, M, van der Holt, B, el Jarari, L, Bertsch, U, Zweegman, S, Buijs, A, Hose, D, Lokhorst, H M, Goldschmidt, H & Sonneveld, P 2013, 'High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance', Blood, vol. 121, no. 4, pp. 624-627. https://doi.org/10.1182/blood-2012-06-438101","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/2b66709f-ec85-43c9-b74e-1a035d536a1c","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/2b66709f-ec85-43c9-b74e-1a035d536a1c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Broijl, A, Kuiper, R, van Duin, M, van der Holt, R, Jarari, L, Bertsch, U, Zweegman, S, Buijs, A, Hose, D, Lokhorst, HM, Goldschmidt, H & Sonneveld, P 2013, 'High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance', Blood, vol. 121, no. 4, pp. 624-627. https://doi.org/10.1182/blood-2012-06-438101","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/2b66709f-ec85-43c9-b74e-1a035d536a1c","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/2b66709f-ec85-43c9-b74e-1a035d536a1c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 121(4), 624 - 627. American Society of Hematology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repub.eur.nl:69768","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/69768","pdf_url":null,"source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood vol. 121 no. 4, pp. 624-627","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:155911","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/high-cereblon-expression-is-associated-with-better-survival-in-patients-with-newly-diagnosed-multiple-myeloma-treated-with-thalidomide-maintenance(f74e7b39-efaf-4e1a-9bee-de5025a9b405).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/b004673c-42e3-4a4e-9767-44f0e03fbc6b","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/b004673c-42e3-4a4e-9767-44f0e03fbc6b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 121(4), 624 - 627. American Society of Hematology","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:repub.eur.nl:69768","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/69768","pdf_url":null,"source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood vol. 121 no. 4, pp. 624-627","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1572662242","https://openalex.org/W1992538067","https://openalex.org/W1997952190","https://openalex.org/W2021954218","https://openalex.org/W2025656486","https://openalex.org/W2025924761","https://openalex.org/W2026448323","https://openalex.org/W2075032656","https://openalex.org/W2096812066","https://openalex.org/W2106101491","https://openalex.org/W2108235071","https://openalex.org/W2112744827","https://openalex.org/W2114217833","https://openalex.org/W2119462367","https://openalex.org/W2124560610","https://openalex.org/W2128084036","https://openalex.org/W2135827569","https://openalex.org/W2142368474"],"related_works":["https://openalex.org/W7005766061","https://openalex.org/W2465356337","https://openalex.org/W2587876253","https://openalex.org/W2025030626","https://openalex.org/W2121039731","https://openalex.org/W2520368275","https://openalex.org/W2980214198","https://openalex.org/W2582570920","https://openalex.org/W4382372812"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1965604161","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":24}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
